Medulloblastoma Group

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-07
Clinical Trial Update: Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of the CHK1 inhibitor prexasertib (LY2606368) in combination with cyclophospham…